Release Date: 21/07/16 17:00 Summary: Quarterly Activities Report-SMC.AX Price Sensitive: Yes Download Document 6.21MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%